Esomeprazole Magnesium Trihydrate EC Pellets Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Esomeprazole Magnesium Trihydrate EC Pellets

Pharmaceutical-Grade Esomeprazole Magnesium Trihydrate Enteric-Coated Pellets for Delayed-Release Oral Multiparticulate Formulations

Esomeprazole Magnesium Trihydrate EC Pellets are pharmaceutical-grade enteric-coated multiparticulate pellets containing Esomeprazole Magnesium Trihydrate. The material has CAS Number 217087-09-7, molecular formula C₃₄H₄₂MgN₆O₉S₂, and molecular weight 767.20 g/mol.

The enteric-coated pellet format is designed to protect the active ingredient from acidic conditions and provide release under higher-pH conditions. Commercial delayed-release capsule formulations of esomeprazole magnesium use enteric-coated pellets, and regulatory documentation describes identification, assay, organic impurities, dissolution and microbiological quality as relevant finished-product controls.

Esomeprazole Magnesium Trihydrate EC Pellets are suitable for pharmaceutical multiparticulate formulation development, capsule filling and enteric-coated pellet applications. The final active loading, coating weight gain, particle-size distribution, gastric resistance and dissolution profile should be controlled according to the applicable product specification.

Key Features

  • Pharmaceutical-grade Esomeprazole Magnesium Trihydrate EC Pellets
  • Enteric-coated multiparticulate format
  • pH-dependent delayed-release design
  • Suitable for oral multiparticulate formulations
  • Suitable for capsule-filling applications
  • Product-specific Esomeprazole loading
  • Controlled gastric resistance
  • Product-specific enteric-coating system
  • Controlled dissolution profile
  • Suitable for pharmaceutical formulation development
  • Suitable for bulk pharmaceutical supply

Enteric-Coated Pellet Technology

Esomeprazole is acid-sensitive, making protection from acidic conditions an important part of the formulation design. Enteric coating is therefore used to provide gastric resistance and facilitate release after exposure to an appropriate higher-pH environment.

Published formulation work has evaluated Esomeprazole Magnesium enteric-coated pellets using an acid-resistance stage followed by phosphate-buffer dissolution testing.

The final release profile depends on factors including:

  • Pellet-core composition
  • Esomeprazole active loading
  • Seal/isolating layer
  • Enteric-polymer type
  • Coating weight gain
  • Coating uniformity
  • Pellet size
  • Dissolution conditions

Why Esomeprazole Magnesium Trihydrate EC Pellets from Swapnroop?

  • Pharmaceutical-Grade Pellets: Designed for pharmaceutical formulation applications.
  • Enteric-Coated Format: Suitable for delayed-release multiparticulate formulations requiring protection from acidic conditions.
  • Product-Specific Active Loading: Esomeprazole concentration is established according to the applicable product specification.
  • Multiparticulate Format: Suitable for capsule-filling and oral formulation development.
  • Controlled Pellet Characteristics: Particle size and other physical parameters can be controlled according to product requirements.
  • Gastric-Resistance Control: Enteric-coating performance can be evaluated according to the applicable specification.
  • Controlled Release Profile: Dissolution characteristics are established according to the applicable formulation and testing specification.
  • Formulation Flexibility: Suitable for different enteric-coated formulation-development requirements.
  • Bulk Pharmaceutical Supply: Suitable for pharmaceutical manufacturing and formulation requirements.

 Applications

Esomeprazole Magnesium Trihydrate EC Pellets can be used for:

  • Enteric-coated oral formulations
  • Delayed-release multiparticulate formulations
  • Capsule-filling applications
  • Gastro-resistant pellet systems
  • Pharmaceutical pellet coating
  • Multiparticulate formulation development
  • pH-dependent release formulations
  • Customized delayed-release formulations
  • Pharmaceutical manufacturing and bulk formulation

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Loss on Drying NMT 3.0%
Residue on Ignition NMT 0.1%
Heavy Metals NMT 10 ppm
Individual Impurity NMT 0.5%
Water Content NMT 3.0%
Get Bulk Quote via WhatsApp